Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

Volume 319:745-752		September 22, 1988		Number 12

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

JL Speyer, MD Green, E Kramer, M Rey, J Sanger, C Ward, N Dubin, V Ferrans, P Stecy, A Zeleniuch-Jacquotte, and et al.

Abstract

Add to Personal Archive

Add to Citation Manager

E-mail When Cited

PubMed Citation

Rita & Stanley Kaplan Cancer Center, New York.

This article has been cited by other articles:

Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N., Sawyer, D. B. (2008). Anthracycline Cardiotoxicity: From Bench to Bedside. JCO 26: 3777-3784 [Abstract] [Full Text]
Steinherz, L. (2008). Early Breast Cancer Therapy and Cardiovascular Injury. J Am Coll Cardiol 51: 1235-1235 [Full Text]
Barry, E. V., Vrooman, L. M., Dahlberg, S. E., Neuberg, D. S., Asselin, B. L., Athale, U. H., Clavell, L. A., Larsen, E. C., Moghrabi, A., Samson, Y., Schorin, M. A., Cohen, H. J., Lipshultz, S. E., Sallan, S. E., Silverman, L. B. (2008). Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane. JCO 26: 1106-1111 [Abstract] [Full Text]
Tebbi, C. K., London, W. B., Friedman, D., Villaluna, D., De Alarcon, P. A., Constine, L. S., Mendenhall, N. P., Sposto, R., Chauvenet, A., Schwartz, C. L. (2007). Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's Disease. JCO 25: 493-500 [Abstract] [Full Text]
Marty, M., Espie, M., Llombart, A., Monnier, A., Rapoport, B. L., Stahalova, V., On behalf of the Dexrazoxane Study Group, (2006). Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane(R)) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy. Ann Oncol 17: 614-622 [Abstract] [Full Text]
Floyd, J. D., Nguyen, D. T., Lobins, R. L., Bashir, Q., Doll, D. C., Perry, M. C. (2005). Cardiotoxicity of Cancer Therapy. JCO 23: 7685-7696 [Abstract] [Full Text]
Hofland, K. F., Thougaard, A. V., Sehested, M., Jensen, P. B. (2005). Dexrazoxane Protects against Myelosuppression from the DNA Cleavage-Enhancing Drugs Etoposide and Daunorubicin but not Doxorubicin. Clin. Cancer Res. 11: 3915-3924 [Abstract] [Full Text]
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., Hurwitz, C. A., Moghrabi, A., Samson, Y., Schorin, M. A., Gelber, R. D., Sallan, S. E. (2004). The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia. NEJM 351: 145-153 [Abstract] [Full Text]
L'Ecuyer, T., Allebban, Z., Thomas, R., Vander Heide, R. (2004). Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death. Am. J. Physiol. Heart Circ. Physiol. 286: H2057-H2064 [Abstract] [Full Text]
Gharib, M.I., Burnett, A.K. (2002). Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis. Eur J Heart Fail 4: 235-242 [Abstract] [Full Text]
Kotamraju, S., Chitambar, C. R., Kalivendi, S. V., Joseph, J., Kalyanaraman, B. (2002). Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells. ROLE OF OXIDANT-INDUCED IRON SIGNALING IN APOPTOSIS. J. Biol. Chem. 277: 17179-17187 [Abstract] [Full Text]
Cardinale, D., Sandri, M. T., Martinoni, A., Borghini, E., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Fiorentini, C., Cipolla, C. M. (2002). Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy. Ann Oncol 13: 710-715 [Abstract] [Full Text]
Tetef, M. L., Synold, T. W., Chow, W., Leong, L., Margolin, K., Morgan, R., Raschko, J., Shibata, S., Somlo, G., Yen, Y., Groshen, S., Johnson, K., Lenz, H.-J., Gandara, D., Doroshow, J. H. (2001). Phase I Trial of 96-Hour Continuous Infusion of Dexrazoxane in Patients with Advanced Malignancies. Clin. Cancer Res. 7: 1569-1576 [Abstract] [Full Text]
Cardinale, D., Sandri, M. T., Martinoni, A., Tricca LabTech, A., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Cipolla, C. M., Fiorentini, C. (2000). Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 36: 517-522 [Abstract] [Full Text]
van Acker, F. A. A., van Acker, S. A. B. E., Kramer, K., Haenen, G. R. M. M., Bast, A., van der Vijgh, W. J. F. (2000). 7-Monohydroxyethylrutoside Protects against Chronic Doxorubicin-induced Cardiotoxicity When Administered Only Once Per Week. Clin. Cancer Res. 6: 1337-1341 [Abstract] [Full Text]
Yoshida, M., Maehara, Y., Sugimachi, K. (1999). MST-16, a Novel Bis-dioxopiperazine Anticancer Agent, Ameliorates Doxorubicin-induced Acute Toxicity While Maintaining Antitumor Efficacy. Clin. Cancer Res. 5: 4295-4300 [Abstract] [Full Text]
Hensley, M. L., Schuchter, L. M., Lindley, C., Meropol, N. J., Cohen, G. I., Broder, G., Gradishar, W. J., Green, D. M., Langdon, R. J. Jr, Mitchell, R. B., Negrin, R., Szatrowski, T. P., Thigpen, J. T., Von Hoff, D., Wasserman, T. H., Winer, E. P., Pfister, D. G. (1999). American Society of Clinical Oncology Clinical Practice Guidelines for the Use of Chemotherapy and Radiotherapy Protectants. JCO 17: 3333-3355 [Abstract] [Full Text]
Feenstra, J., Grobbee, D. E., Remme, W. J., Stricker, B. H. C. (1999). Drug-induced heart failure. J Am Coll Cardiol 33: 1152-1162 [Abstract] [Full Text]
Klein, P., Muggia, F. M. (1999). Cytoprotection: Shelter from the Storm. The Oncologist 4: 112-121 [Full Text]
Sawyer, D. B., Fukazawa, R., Arstall, M. A., Kelly, R. A. (1999). Daunorubicin-Induced Apoptosis in Rat Cardiac Myocytes Is Inhibited by Dexrazoxane. Circ. Res. 84: 257-265 [Abstract] [Full Text]
MINOTTI, G., CAIRO, G., MONTI, E. (1999). Role of iron in anthracycline cardiotoxicity: new tunes for an old song?. FASEB J. 13: 199-212 [Abstract] [Full Text]
O'Marcaigh, A. S., Betcher, D. L. (1997). Dexrazoxane (ICRF-187): A Cardioprotective Agent During Anthracycline Chemotherapy. Journal of Pediatric Oncology Nursing 14: 96-98
Dunn, J. (1994). Doxorubicin-Induced Cardiomyopathy. Journal of Pediatric Oncology Nursing 11: 152-160 [Abstract]
Davis, L. E. (1991). Long-Term Complications of Antineoplastic Agents. Journal of Pharmacy Practice 4: 131-150

Comments and questions? Please contact us.